Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer | NEJM
Platinum-based chemotherapy is the recommended adjuvant treatment for patients with resectable, ALK-positive non–small-cell lung cancer (NSCLC). Data on the efficacy and safety of adjuvant alectini…